Muhammad Bilal Abid

29PUBLICATIONS
139CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jul 02, 2026
Real-World Outcomes with BCMA- and GPRC5D-Targeting Bispecific Antibodies in Plasma Cell Leukemia.

|Jun 08, 2026
Cost-effective analysis of teclistamab and daratumumab versus ciltacabtagene autoleucel in relapsed multiple myeloma.

|May 11, 2026
Bispecific Antibodies in Hematologic Malignancies in the Outpatient and Community Settings.

|Jul 22, 2025
Chimeric antigen receptor T-cell therapy for high-grade B-cell lymphoma NOS.

Nasheed M Hossain, Kwang Woo Ahn, Jinalben Patel

|May 29, 2025
Efficacy of Total-Body Irradiation-based Intensified Myeloablative Regimens for Acute Leukemia-An International Collaborative Study.

Yasuyuki Arai, Ruta Brazauskas, Naya He

|May 28, 2025
Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR.

Kitsada Wudhikarn, Megan M Herr, Min Chen

Pageof 5

Frequent Collaborators

5 joint publications

Akshay Sharma

3 joint publications

Sachiko Seo

3 joint publications

Michael R Grunwald

3 joint publications

Mohamed A Kharfan-Dabaja